'Turning point' in dementia fight as new drug slows Alzheimer's by up to 60 percent

An experimental drug called donanemab has shown remarkable success in slowing Alzheimer’s by up to 60 percent.

This article, images and content belong to the source and curated for informational purposes.

‘Turning point’ in dementia fight as new drug slows Alzheimer’s by up to 60 percent